118 related articles for article (PubMed ID: 1428472)
1. Relationship of blood prolactin levels and the risk of subsequent breast cancer.
Wang DY; De Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Fentiman IS; Hayward JL; Millis RR
Int J Epidemiol; 1992 Apr; 21(2):214-21. PubMed ID: 1428472
[TBL] [Abstract][Full Text] [Related]
2. The relationship between blood prolactin levels and risk of breast cancer in premenopausal women.
Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Chaudary M; Hayward JL
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1541-8. PubMed ID: 3678318
[TBL] [Abstract][Full Text] [Related]
3. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
Eliassen AH; Tworoger SS; Hankinson SE
Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859
[TBL] [Abstract][Full Text] [Related]
4. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women.
Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Hayward JL; Gravelle IH
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1225-31. PubMed ID: 3416905
[TBL] [Abstract][Full Text] [Related]
5. Plasma prolactin and its relationship to risk factors in human breast cancer.
Kwa HG; Cleton F; de Jong-Bakker M; Bulbrook RD; Hayward JL; Wang DY
Int J Cancer; 1976 Apr; 17(4):441-7. PubMed ID: 945228
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.
Hankinson SE; Willett WC; Michaud DS; Manson JE; Colditz GA; Longcope C; Rosner B; Speizer FE
J Natl Cancer Inst; 1999 Apr; 91(7):629-34. PubMed ID: 10203283
[TBL] [Abstract][Full Text] [Related]
8. Relationship between plasma progesterone, estradiol and prolactin concentrations and breast cancer in pre and postmenopausal women.
Raheem SN; Atoum M; Al-Hourani H; Rasheed M; Nimer N; Almuhrib T
Neoplasma; 2010; 57(1):74-8. PubMed ID: 19895176
[TBL] [Abstract][Full Text] [Related]
9. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
10. Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth.
Kwa HG; Cleton F; Bulbrook RD; Wang DY; Hayward JL
Int J Cancer; 1981 Jul; 28(1):31-4. PubMed ID: 7309279
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
12. Nyctohemeral changes in plasma prolactin levels and their relationship to breast cancer risk.
Wang DY; Sturzaker HE; Kwa HG; Verhofstad F; Hayward JL; Bulbrook RD
Int J Cancer; 1984 May; 33(5):629-32. PubMed ID: 6724738
[TBL] [Abstract][Full Text] [Related]
13. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment.
de Waard F; Kwa HG; Poortman J
Oncology; 1980; 37(1):33-6. PubMed ID: 7350553
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of plasma prolactin levels and subsequent risk of breast cancer.
Kwa HG; Cleton F; Wang DY; Bulbrook RD; Bulstrode JC; Hayward JL; Millis RR; Cuzick J
Int J Cancer; 1981 Dec; 28(6):673-6. PubMed ID: 7333701
[TBL] [Abstract][Full Text] [Related]
15. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.
Tikk K; Sookthai D; Fortner RT; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Ricceri F; Mattiello A; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; Monninkhof EM; Onland-Moret NC; Andresson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Merritt MA; Riboli E; Dossus L; Kaaks R
Breast Cancer Res; 2015 Mar; 17(1):49. PubMed ID: 25887963
[TBL] [Abstract][Full Text] [Related]
16. A review of the epidemiology of human breast cancer.
Kelsey JL
Epidemiol Rev; 1979; 1():74-109. PubMed ID: 398270
[TBL] [Abstract][Full Text] [Related]
17. Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer.
Love RR; Rose DR; Surawicz TS; Newcomb PA
Cancer; 1991 Sep; 68(6):1401-5. PubMed ID: 1873792
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease.
Tarquini A; di Martino L; Malloci A; Kwa HG; van der Gugten AA; Bulbrook RD; Wang DY
Int J Cancer; 1978 Dec; 22(6):687-90. PubMed ID: 721323
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and breast cancer risk.
Ingram DM; Nottage EM; Roberts AN
Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipids and prolactin in patients with breast cancer.
Bani IA; Williams CM; Boulter PS; Dickerson JW
Br J Cancer; 1986 Sep; 54(3):439-46. PubMed ID: 3756079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
